Monday, September 16, 2024

Creating liberating content

Oracle Corp’s (NYSE: ORCL)...

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15%...

RTX Corp (NYSE: RTX)...

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03...

GameStop Corp. (NYSE:GME) Quarter...

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after...

Advanced Micro Devices (NASDAQ:AMD)...

Shares of Advanced Micro Devices (NASDAQ:AMD) drops 0.38% in afterhours in last trading...
HomeTagsAstraZeneca plc’s (NASDAQ: AZN)

Tag: AstraZeneca plc’s (NASDAQ: AZN)

AstraZeneca plc’s (NASDAQ: AZN) Evusheld...

The Japanese regulatory authority has authorized Evusheld...

AstraZeneca plc’s (NASDAQ: AZN) Evusheld Permitted by Japanese Authority For COVID-19 Treatment

The Japanese regulatory authority has authorized Evusheld (tixagevimab and cilgavimab, previously AZD7442) by AstraZeneca plc (NASDAQ:AZN), a long-acting antibody combination for the prevention (pre-exposure prophylaxis) and treatment of COVID-19. The result represents Evusheld's first global commercial clearance as a therapy for COVID-19. The Japanese government has committed to buy 300,000 units of Evusheld (150mg tixagevimab and cilgavimab each), and AstraZeneca is working with the government and partners to get the first doses to patients as quickly as feasible. The approvals were based on the clinical development program at Evusheld, which included...

AstraZeneca plc’s (NASDAQ:...

The Japanese regulatory authority has authorized Evusheld (tixagevimab and cilgavimab, previously AZD7442) by AstraZeneca plc (NASDAQ:AZN), a long-acting antibody combination for the prevention (pre-exposure...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!